Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 456 | 43 | 111 | 529 | 1 |
| Gross Profit | 456 | 43 | 111 | 529 | 1 |
| Operating Expenses | 38,505 | 28,338 | 25,964 | 22,998 | 19,360 |
| Operating Income | -38,049 | -28,295 | -25,853 | -22,469 | -19,359 |
| Other Income | 6,251 | 7,890 | 6,951 | 5,535 | 2,800 |
| Pre-tax Income | -31,798 | -20,405 | -18,902 | -16,934 | -16,559 |
| Net Income Continuous | -31,798 | -20,405 | -18,902 | -16,934 | -16,559 |
| Net Income | $-31,798 | $-20,405 | $-18,902 | $-16,934 | $-16,559 |
| EPS Basic Total Ops | -0.47 | -0.30 | -0.28 | -0.36 | -4.50 |
| EPS Basic Continuous Ops | -0.46 | -0.30 | -0.28 | -0.36 | -3.33 |
| EPS Diluted Total Ops | -0.47 | -0.30 | -0.28 | -0.36 | -4.50 |
| EPS Diluted Continuous Ops | -0.46 | -0.30 | -0.28 | -0.36 | -3.33 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.30 | -0.28 | N/A | N/A |
| EBITDA(a) | $-36,794 | $-29,856 | $-28,312 | $-24,664 | $-20,810 |